POTASSIUM CHLORIDE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: POTASSIUM CHLORIDE
Generic name: POTASSIUM CHLORIDE
Manufacturer: Epic Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 1373321f-533a-4ab4-8bcd-8bde15371a09
SPL ID: 58c7eab4-f697-478c-be72-4cba3e74dc2c
Version: 8
Effective date: 2024-08-13
Source export date: 2026-10-12
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/7928c8e8c6256620071a8b7e5b93eb8dfa543649c08d17a01ea02251012ba58c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:25:20

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 16 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	210200	derived:openfda.application_number
application number		ANDA210200	openfda.application_number
brand name		POTASSIUM CHLORIDE	openfda.brand_name
generic name		POTASSIUM CHLORIDE	openfda.generic_name
manufacturer name		Epic Pharma, LLC	openfda.manufacturer_name
ndc	package	42806-094-99	openfda.package_ndc
ndc	package	42806-094-01	openfda.package_ndc
ndc	package	42806-094-30	openfda.package_ndc
ndc	product	42806-094	openfda.product_ndc
ndc11	package	42806009430	derived:openfda.package_ndc
ndc11	package	42806009401	derived:openfda.package_ndc
ndc11	package	42806009499	derived:openfda.package_ndc
rxcui		1867544	openfda.rxcui
spl id		58c7eab4-f697-478c-be72-4cba3e74dc2c	id
spl set id		1373321f-533a-4ab4-8bcd-8bde15371a09	set_id
unii		660YQ98I10	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

5 WARNINGS AND PRECAUTIONS • Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1 )].

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Epic Pharma, LLC at 1-888-374-2791 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.